Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Giuseppe Vella has a total of 106 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Trends and Characterization of Hospitalizations with Heart Failure in Italy Before and During the COVID-19 Pandemic

    by Emanuele Amodio, Giovanni Tinervia, Sofia Bellomo, Michela Conti, Dario Genovese, Gabriele Biagio Marrella, Domenica Matranga, Aurelio Seidita, Giuseppe Vella, Marco Enea

    Background/Objectives: Heart failure (HF) imposes a significant healthcare burden in aging populations. The COVID-19 pandemic disrupted care, raising concerns about chronic disease management. We analyzed temporal trends in HF hospitalizations in Italy (2008–2022), assessing the influence of demographics, clinical complexity, seasonality, and the pandemic. Methods: Using national discharge records, we strictly identified hospitalizations with a primary HF diagnosis via ICD-9-CM codes. Admissions were stratified by age, sex, season, and clinical severity according to the Elixhauser Comorbidity Index. Temporal trends were analyzed using a Negative Binomial Generalized Linear Mixed Model with the time component modeled through a segmented regression to account for pre-pandemic, pandemic (2020), and late-pandemic dynamics. Results: We identified 3,162,075 primary HF admissions, yielding a crude hospitalization rate of 35.11 per 10,000 person-years. Patients with an intermediate comorbidity burden (Elixhauser 13–20) accounted for 59.3% of the total volume. Multivariable analysis identified male sex (RR = 2.24, p < 0.001 ***), age ≥ 75 years (RR = 95.04 vs. 25–44, p < 0.001 ***), and winter seasonality as strong independent predictors. Trend analysis revealed a structural long-term decline across all severity tiers, driven by a sharp drop in 2020 (RR = 0.80, p < 0.001 ***) coincident with a spike in in-hospital mortality. While patients with low-to-intermediate comorbidity exhibited a partial rebound in 2021–2022 (overall RR = 1.06, p < 0.001 ***), admissions for highly complex patients (score > 20) showed an accelerated late-pandemic decline. Conclusions: HF hospitalizations in Italy remain a substantial burden driven by advanced age and clinical comorbidity. Our 15-year population-level data indicate no sustained, structural late-pandemic surge in HF admissions. The observed fluctuations were likely driven by severe healthcare disruptions and patient care avoidance rather than a true epidemiological shift, highlighting the urgent need for resilient chronic care systems during emergencies.

  • Open Access

    What do Italian Adolescents Know about HPV and the HPV Vaccination? Results of an Observational Study

    by Laura Brunelli, Francesca Valent, Manola Comar, Barbara Suligoi, Maria Cristina Salfa, Daniele Gianfrilli, Franz Sesti, Giuseppina Capra, Alessandra Casuccio, Silvia Gazzetta, et al.

    Background/Objectives: HPV is the most common sexually transmitted infectious agent worldwide and adolescents are at high risk of becoming infected with HPV. Our study aimed at understanding how much adolescents know about the virus and its effects, and to obtain infor-mation on attitudes and behaviors regarding HPV vaccination to close these gaps. Methods: Within the ESPRIT project, 598 lower and upper secondary school students from 3 Italian regions were surveyed between December 2023 and March 2024 using an online questionnaire with 7 questions on awareness, knowledge and attitudes towards HPV and the HPV vaccine. A regres-sion model was used to determine correlations based on sex, living context, province of residence and school type. Results: Younger students believed that HPV causes HIV/AIDS (8.9%) or hepati-tis C (3.0%) and rarely mentioned anal (21%) and oral sex (9.6%) as ways of transmission. Among older students the misconceptions were similar, with worrying rates of students stating that HPV causes cancer only in women (18%) or men (2.4%), and low rates of identifying trans-mission risk from anal (41%) and oral (34%) intercourse and genital contact (38%). HPV vac-cination rate was quite low (47% in younger, 61% in older students). Considering regressions, the living context was decisive for the knowledge of younger students; sex, school type and province of residence in older students. Conclusions: Awareness and knowledge of HPV and the HPV vaccine are low among Italian students, and reported vaccination coverage is below the national target. Coordinated efforts at national level are needed to address this public health issue.

  • Open Access

    Challenges and Alternatives to Evaluation Methods and Regulation Approaches for Medical Apps as Mobile Medical Devices: International and Multidisciplinary Focus Group Discussion

    by Laura Maaß, Robert Hrynyschyn, Martin Lange, Alexandra Löwe, Kathrin Burdenski, Kaley Butten, Sebastian Vorberg, Mariam Hachem, Aldo Gorga, Vittorio Grieco, et al.

    Background: The rapid proliferation of medical apps has transformed the health care landscape by giving patients and health care providers unprecedented access to personalized health information and services. However, concerns regarding the effectiveness and safety of medical apps have raised questions regarding the efficacy of randomized controlled trials (RCTs) in the evaluation of such apps and as a requirement for their regulation as mobile medical devices. Objective: This study aims to address this issue by investigating alternative methods, apart from RCTs, for evaluating and regulating medical apps. Methods: Using a qualitative approach, a focus group study with 46 international and multidisciplinary public health experts was conducted at the 17th World Congress on Public Health in May 2023 in Rome, Italy. The group was split into 3 subgroups to gather in-depth insights into alternative approaches for evaluating and regulating medical apps. We conducted a policy analysis on the current regulation of medical apps as mobile medical devices for the 4 most represented countries in the workshop: Italy, Germany, Canada, and Australia. We developed a logic model that combines the evaluation and regulation domains on the basis of these findings. Results: The focus group discussions explored the strengths and limitations of the current evaluation and regulation methods and identified potential alternatives that could enhance the quality and safety of medical apps. Although RCTs were only explicitly mentioned in the German regulatory system as one of many options, an analysis of chosen evaluation methods for German apps on prescription pointed toward a “scientific reflex” where RCTs are always the chosen evaluation method. However, this method has substantial limitations when used to evaluate digital interventions such as medical apps. Comparable results were observed during the focus group discussions, where participants expressed similar experiences with their own evaluation approaches. In addition, the participants highlighted numerous alternatives to RCTs. These alternatives can be used at different points during the life cycle of a digital intervention to assess its efficacy and potential harm to users. Conclusions: It is crucial to recognize that unlike analog tools, digital interventions constantly evolve, posing challenges to inflexible evaluation methods such as RCTs. Potential risks include high dropout rates, decreased adherence, and nonsignificant results. However, existing regulations do not explicitly advocate for other evaluation methodologies. Our research highlighted the necessity of overcoming the gap between regulatory demands to demonstrate safety and efficacy of medical apps and evolving scientific practices, ensuring that digital health innovation is evaluated and regulated in a way that considers the unique characteristics of mobile medical devices.


  • Open Access

    Self-Perceived Competencies and Attitudes on Palliative Care in Undergraduate Nursing Students: A Multicenter Descriptive Study

    by Cinzia Lo Iacono, Emanuele Amodio, Giuseppe Vella, Maria Caruso, Giuseppe D’anna, Angelo Gambera, Maurizio Soresi, Giuseppe Intravaia, Roberto Latina

    Introduction: Caring for the dying can generate anxiety and emotional distress, particularly in nursing students, and perceived competence could play a crucial role in enabling nurses to perform their duties with greater confidence. Unfortunately, few studies describe the relationship between students’ nursing attitudes and perceived self-efficacy in palliative care (PC). To overcome this gap, this survey aimed to assess the attitudes towards dying patients and the perceived competence of nursing students in palliative care at different universities in the south of Italy. Methods: A cross-sectional study was conducted from September 2022 to March 2023 involving nursing students from the three major Sicilian universities (Italy). The study included a survey investigating socio-demographic characteristics, palliative care training, knowledge about pain management, and previous experience with dying. Moreover, the Professional Competence of the Core Curriculum in Palliative Care Nursing (CCPCN) questionnaire and the Frommelt Attitudes Toward Care of the Dying—B Italian version (FATCOD-B-I) assessed competencies and emotional attitudes. Results: A total of 1913 nursing students were recruited, of which 71.3% were females, and 53.9% were in the age range of 18 to 21 years. In the multivariable analysis, practical PC training was a substantial factor in enhancing competencies (Adj-OR 2.78 [95% CI = 2.12–3.65]). Male students had higher competence odds (Adj-OR 1.38 [95% CI = 1.14–1.66]), and perceived knowledge strongly correlated with self-assessed competence. Advancement in academic years also positively influenced competence self-assessment (Adj-OR 1.98 [95% CI = 1.75–2.24]). Regarding emotional attitudes, a per-quartile increase in competence score was found to improve the attitude score (Adj-OR 1.24 [95% CI = 1.13–1.35]). Conclusions: Nursing students gain valuable experience during clinical experience. PC training and perceived knowledge of PC significantly increase nurses’ competencies, and the latter seem to be strongly associated with attitudes. Thus, introducing palliative care education into nurses’ core curricula could be a way to reduce anxiety and emotional distress in young students.


  • Open Access

    Increase of multidrug-resistant bacteria after the COVID-19 pandemic in a major teaching Hospital in Sicily (2018-2021)

    by Emanuele Amodio, Stefano Pizzo, Giuseppe Vella, Valerio De Francisci, Salvatore Antonino Distefano, Eliana Giambelluca, Domenico Graceffa, Maria Gabriella Verso, Ettore Piro, Mario Giuffrè, et al.


  • Open Access

    Challenges and Alternatives to Evaluation Methods and Regulation Approaches for Medical Apps as Mobile Medical Devices: International and Multidisciplinary Focus Group Discussion (Preprint)

    by Laura Maaß, Robert Hrynyschyn, Martin Lange, Alexandra Löwe, Kathrin Burdenski, Kaley Butten, Sebastian Vorberg, Mariam Hachem, Aldo Gorga, Vittorio Grieco, et al.

    BACKGROUND The rapid proliferation of medical apps has transformed the health care landscape by giving patients and health care providers unprecedented access to personalized health information and services. However, concerns regarding the effectiveness and safety of medical apps have raised questions regarding the efficacy of randomized controlled trials (RCTs) in the evaluation of such apps and as a requirement for their regulation as mobile medical devices. OBJECTIVE This study aims to address this issue by investigating alternative methods, apart from RCTs, for evaluating and regulating medical apps. METHODS Using a qualitative approach, a focus group study with 46 international and multidisciplinary public health experts was conducted at the 17th World Congress on Public Health in May 2023 in Rome, Italy. The group was split into 3 subgroups to gather in-depth insights into alternative approaches for evaluating and regulating medical apps. We conducted a policy analysis on the current regulation of medical apps as mobile medical devices for the 4 most represented countries in the workshop: Italy, Germany, Canada, and Australia. We developed a logic model that combines the evaluation and regulation domains on the basis of these findings. RESULTS The focus group discussions explored the strengths and limitations of the current evaluation and regulation methods and identified potential alternatives that could enhance the quality and safety of medical apps. Although RCTs were only explicitly mentioned in the German regulatory system as one of many options, an analysis of chosen evaluation methods for German apps on prescription pointed toward a “scientific reflex” where RCTs are always the chosen evaluation method. However, this method has substantial limitations when used to evaluate digital interventions such as medical apps. Comparable results were observed during the focus group discussions, where participants expressed similar experiences with their own evaluation approaches. In addition, the participants highlighted numerous alternatives to RCTs. These alternatives can be used at different points during the life cycle of a digital intervention to assess its efficacy and potential harm to users. CONCLUSIONS It is crucial to recognize that unlike analog tools, digital interventions constantly evolve, posing challenges to inflexible evaluation methods such as RCTs. Potential risks include high dropout rates, decreased adherence, and nonsignificant results. However, existing regulations do not explicitly advocate for other evaluation methodologies. Our research highlighted the necessity of overcoming the gap between regulatory demands to demonstrate safety and efficacy of medical apps and evolving scientific practices, ensuring that digital health innovation is evaluated and regulated in a way that considers the unique characteristics of mobile medical devices.

  • Open Access

    Low Risk of SARS-CoV-2 Reinfection for Fully or Boosted mRNA Vaccinated Subjects in Sicily: A Population-Based Study Using Real-World Data

    by Laura Maniscalco, Dario Genovese, Barbara Ravazzolo, Giuseppe Vella, Benedetta Sparacia, Francesco Vitale, Domenica Matranga, Emanuele Amodio

    Background: Reinfections occur as a response to natural infections wanes and novel strains of SARS-CoV-2 emerge. The present research explored the correlation between sex, age, COVID-19 vaccination, prior infection hospitalization, and SARS-CoV-2 reinfection in Sicily, Italy. Materials and Methods: A population-based retrospective cohort study was articulated using the vaccination flux from a regional registry and the Sicilian COVID-19 monitoring system of the Italian Institute of Health. Only adult Sicilians were included in the study, and hazard ratios were calculated using Cox regression. Results: Partial vaccination provided some protection (adj-HR: 0.92), when compared to unvaccinated individuals; furthermore, reinfection risk was reduced by full vaccination (adj-HR: 0.43), and the booster dose (adj-HR: 0.41). Males had a lower risk than females of reinfection with SARS-CoV-2 (adj-HR: 0.75). Reinfection with SARS-CoV-2 was diminished by hospitalization during the first infection (adj-HR: 0.78). Reinfection risk was higher among those aged 30–39 and 40–49 compared to those aged 18–29, whereas those aged 60–69, 70–79, and 80+ were statistically protected. Reinfection was significantly more frequent during the wild-type–Alpha, Delta, Delta–Omicron, and Omicron dominance/codominance waves compared to the wild type. Conclusions: This study establishes a solid base for comprehending the reinfection phenomenon in Sicily by pinpointing the most urgent policy hurdles and identifying some of the major factors. COVID-19 vaccination, one of the most effective public health tools, protects against reinfection, mostly caused by the Omicron strain. Elderly and hospitalized people’s lower risk suggests stricter PPE use.

  • Open Access

    Increase of multidrug-resistant bacteria after the COVID-19 pandemic in a major teaching Hospital in Sicily (2018-2021)

    by Emanuele Amodio, Stefano Pizzo, Giuseppe Vella, Valerio De Francisci, Salvatore Antonino Distefano, Eliana Giambelluca, Domenico Graceffa, Maria Gabriella Verso, Giovanni Giammanco, Giuseppe Calamusa

    Introduction The COVID-19 pandemic has further highlighted the continuing threat of antimicrobial resistance (AMR) to global health and economic development. In the last two decades, AMR has raised increasing concern with an estimated 4.95 million deaths globally due to bacterial AMR in 2019 alone. This study aims to analyze the impact of the pandemic on the spread of multi-drug resistant organisms (MDROs) using data from the Hospital «P. Giaccone» in Palermo, comparing pre-pandemic and pandemic periods. Methods This observational study involved adult patients discharged from the hospital between 01/01/2018-31/12/2021. Hospital Discharge Cards were linked with microbiological laboratory reports to assess MDRO isolations. SARS-CoV-2 positivity during hospitalization was evaluated using the National Institute of Health's surveillance system. Results This study evaluated 58,427 hospitalizations, where half of the patients were over 65 years old (N=26,984) and most admissions were in the medical area (N=31,716). During the hospitalization period, the isolated MDRO were 2,681 (5%), whereas there were 946 subjects (2%) positive for SARS-CoV-2. In the multivariable analyses, during 2020 and 2021 there was a significant increased risk of isolation of Staphylococcus aureus, Acinetobacter baumannii, and Klebsiella pneumoniae. Age, DRG-weight, and length-of-stay were associated to a higher risk of MDRO isolation. Conclusion Our study provides new insights into the impact of the COVID-19 pandemic on MDRO isolation and has important implications for infection control and prevention efforts in healthcare facilities. Age, DRG-weight, and longer hospital stays further increase the risk of MDRO isolation. Thus, it is imperative to improve and follow hospital protocols to prevent healthcare-associated infections.

  • Open Access

    Risk of sars-cov-2 reinfection in sicily: A population-based evaluation of covid-19 events using current health databases

    by Dario Genovese, Domenica Matranga, Laura Maniscalco, Vincenzo Pisciotta, Giuseppe Vella, Alessandra Casuccio, Emanuele Amodio

    Background and Objective: Worldwide, the COVID-19 outbreak resulted in more than 640 million cases as of 15 December 2022. As immunity to natural infection deteriorates with time and SARS-CoV-2 strains mutate, reinfections began to occur. The current study sought to assess the probability of...

  • Open Access

    Effectiveness of mRNA Vaccine Booster against SARS-CoV-2 Infection and COVID-19 in the Adult Population during the First Three Months of the Omicron Wave in Sicily

    by Giuseppe Vella, Dario Genovese, Miriam Belluzzo, Luca Mazzeo, Vincenzo Pisciotta, Emanuele Amodio

    Background: In Italy, the administration of the COVID-19 vaccine booster dose started on 27 September 2021, supported by clinical trials corroborating its efficacy. Given the paucity of real-world effectiveness data, this study aims to estimate the vaccine effectiveness of the booster dose against SARS-CoV-2 infection, severe disease, and death in the adult Sicilian population. Methods: This retrospective cohort study was carried out from 1 January to 31 March 2022 and included all residents in Sicily aged ≥ 18 years without previous SARS-CoV-2 infection and with a complete mRNA vaccine primary cycle. The cohort was split into two groups (booster and primary cycle) matched by age, gender, vaccine type, and month of completion of the primary vaccination cycle. Results: 913,382 subjects were observed in the study: 456,690 (50%) were vaccinated with two doses and 456,692 (50%) with three doses. There were 43,299 cases of SARS-CoV-2 among the two-doses vaccinees (9.5%) and 10,262 (2.2%) among the three-doses counterpart. Vaccine effectiveness in the booster cohort was 76.5% and 74.4% against SARS-CoV-2 infection, 85.7% and 79.7% against severe disease, and 84.1% and 73.1% against intubation or death, for BNT162b2 and mRNA-1273, respectively. Conclusions: This study confirmed the remarkable efficacy profile of the SARS-CoV-2 vaccine booster dose against infection, severe disease, and death attributable to the virus. Overall, the results of this study provide important real-world data to support the continued roll-out of the COVID-19 booster dose and have the potential to inform public health policy and guide decisions on vaccination strategies in countries around the world.